DrugDashboards

Market view

tobramycin sulfate · Injection, Powder, Lyophilized, For Solution

2 marketed package NDCs · 1 active manufacturer

Most dispensed: 40 mg/mL · Injection, Solution · #25 vial, multi-doses/tray / 2 ml in 1 vial, multi-dose

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

What changed in the last 90 days

Every detected change for tobramycin sulfate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • TobramycinAug 19, 2026
    Price up
    NADAC $0.65006 → $0.73949 per unit (+13.76%)
  • TobramycinJul 22, 2026
    Price down
    NADAC $0.65275 → $0.65006 per unit (-0.41%)

Same drug class

Other molecules FDA puts in Aminoglycoside Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Tobramycin sulfate in shortage right now?
No. FDA does not currently list Tobramycin sulfate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Tobramycin sulfate?
8 companies have marketed Tobramycin sulfate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Tobramycin sulfate cost?
The typical pharmacy pays about $0.7395 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.